UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025966
Receipt number R000029763
Scientific Title Study on improvement of skin quality with almond chocolate intake
Date of disclosure of the study information 2017/02/02
Last modified on 2017/07/07 17:06:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on improvement of skin quality with almond chocolate intake

Acronym

Study on improvement of skin quality with almond chocolate intake

Scientific Title

Study on improvement of skin quality with almond chocolate intake

Scientific Title:Acronym

Study on improvement of skin quality with almond chocolate intake

Region

Japan


Condition

Condition

healthy volunteer

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Study on skin quality improvement effect when almond chocolate is continuously ingested for 8 weeks

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) defecation, flights, flights quantity, bowel movement days
2) stratum corneum turnover
3) serum inflammatory markers (TARC) 4) by dermatologist skin drying condition rating
5) stratum corneum moisture volume 6) percutaneous skin moisture transpiration rate amount
7) skin image analysis (age spots, wrinkles, texture, quantitative evaluation of pores, UV spots, Porphyrin, Brown freckles (melanin), red (hemoglobin))
8) awareness survey (investigation of subjective symptoms of intestinal and skin)

Key secondary outcomes

1) skin enlarged image
2) Lipids in the stratum corneum (horny cell covalently bonded ceramide)
3) Blood spoilage product
4) Eye buttock ski score evaluation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Test food intake group (8 grains a day for 8weeks)

Interventions/Control_2

Test food non-intake group (8 weeks)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit

49 years-old >=

Gender

Female

Key inclusion criteria

1) Those who received a sufficient explanation of the purpose and contents of this exam, who have the capacity to consent, voluntarily volunteer with full understanding, and who agreed to participate in the document
2) Women who are 25 years old or older and under 50 years old who have a defecation frequency of 2 to 4 times per week for the most recent 2 weeks at the time of screening
3) Person who has conscious of drying of skin at screening

Key exclusion criteria

1) Currently, those who have some sort of chronic illness and are undergoing drug treatment
2) Persons who have severe hay fever symptoms
3) Persons who have significant abnormalities in the skin condition of the test site
4) Persons who are allergic to cocoa, almonds, milk, wheat, eggs, soybeans
5) Persons who regularly consume cacao products, nuts on a daily basis
6) Those who ingested or ingested medicines, quasi-drugs, supplements, health foods, foods for specified health use, functional display foods that are likely to affect this test in the course of three months before screening , Those who are scheduled to take or intake during the exam
7) Persons conducting special facial care (Facial Equipment, Aesthetic, Peeling, Laser Therapy etc.)
8) Participants in other clinical and monitoring studies during the first month before screening
9) Persons who are pregnant, plan for pregnancy during the examination period, those whohave hope
10) Breast feeding
11) Others who judged that the investigatoror the test sharing doctor is inappropriateas the subject

Target sample size

70


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Maiko Tajima

Organization

Beauty & Health Research_Inc

Division name

Medical Research Department

Zip code


Address

Sankyo Nisisinnjuku Buiding 4F 4-2-18 Nisisinnjuku Shinjuku-ku Tokyo, 160-0023 Japan

TEL

03-5354-7388

Email

info@b-hr.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ai Marume

Organization

Beauty & Health Research_Inc

Division name

Medical Research Department

Zip code


Address

Sankyo Nisisinnjuku Buiding 4F 4-2-18 Nisisinnjuku Shinjuku-ku Tokyo, 160-0023 Japan

TEL

03-5354-7388

Homepage URL


Email

marume@b-hr.jp


Sponsor or person

Institute

Beauty & Health Research Inc

Institute

Department

Personal name



Funding Source

Organization

Meiji Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社ビューティアンドヘルスリサーチ(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 12 Month 21 Day

Date of IRB


Anticipated trial start date

2017 Year 02 Month 05 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 02 Month 02 Day

Last modified on

2017 Year 07 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029763


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name